The global in vitro fertilization (IVF) treatment market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing number of couples who are opting for IVF treatments due to various reasons such as infertility, age-related issues, and other medical conditions.
The global in vitro fertilization (IVF) treatment market has been segmented on the basis of type into VET, ICSI, PGD and IVF treatments; by application into fertility clinics, hospitals and research centers; and by region into North America, Latin America, Europe Asia Pacific and Middle East & Africa.
Some Of The Growth Factors Of This Market:
- In addition, the rising awareness about infertility and its treatment among people is also expected to fuel the demand for IVF treatments in the near future.
- Moreover, technological advancements in ARTs are also anticipated to positively impact this market over the forecast period.
- Increasing government funding for research and development activities related to infertility and its treatment are also expected to provide opportunities for growth.
Industry Growth Insights published a new data on “In Vitro Fertilization (IVF) Treatment Market”. The research report is titled “In Vitro Fertilization (IVF) Treatment Market research by Types (VF-ET, ICSI, PGD, In Vitro Fertilization (IVF) Treatmen), By Applications (Fertility Clinics, Hospitals, Reaearch Centers), By Players/Companies AMP Center St Roch, AVA Clinic, Bangkok IVF Center, Betamedics, Bloom Fertility Center, Bourn Hall, CHA Fertility Center, Chelsea and Westminster Hospital, Cloudnine Fertility, Cyprus IVF Centre, Dansk Fertilitetsklinik, FIV Marbella, Genea Oxford Fertility, Houston Fertility Center, IVI Panama, Lifesure Fertility and Gynaecology Centre, LIV Fertility Center, Manipal Fertility, OVA IVF, Procrea Fertility, In Vitro Fertilization (IVF) Treatmen”.
Scope Of The Report
Report Attributes
Report Details
Report Title
In Vitro Fertilization (IVF) Treatment Market Research Report
By Type
VF-ET, ICSI, PGD, In Vitro Fertilization (IVF) Treatmen
By Application
Fertility Clinics, Hospitals, Reaearch Centers
By Companies
AMP Center St Roch, AVA Clinic, Bangkok IVF Center, Betamedics, Bloom Fertility Center, Bourn Hall, CHA Fertility Center, Chelsea and Westminster Hospital, Cloudnine Fertility, Cyprus IVF Centre, Dansk Fertilitetsklinik, FIV Marbella, Genea Oxford Fertility, Houston Fertility Center, IVI Panama, Lifesure Fertility and Gynaecology Centre, LIV Fertility Center, Manipal Fertility, OVA IVF, Procrea Fertility, In Vitro Fertilization (IVF) Treatmen
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
232
Number of Tables & Figures
163
Customization Available
Yes, the report can be customized as per your need.
 Treatment Industry Outlook.svg)
Global In Vitro Fertilization (IVF) Treatment Market Report Segments:
The global In Vitro Fertilization (IVF) Treatment market is segmented on the basis of:
Types
VF-ET, ICSI, PGD, In Vitro Fertilization (IVF) Treatmen
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Fertility Clinics, Hospitals, Reaearch Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AMP Center St Roch
- AVA Clinic
- Bangkok IVF Center
- Betamedics
- Bloom Fertility Center
- Bourn Hall
- CHA Fertility Center
- Chelsea and Westminster Hospital
- Cloudnine Fertility
- Cyprus IVF Centre
- Dansk Fertilitetsklinik
- FIV Marbella
- Genea Oxford Fertility
- Houston Fertility Center
- IVI Panama
- Lifesure Fertility and Gynaecology Centre
- LIV Fertility Center
- Manipal Fertility
- OVA IVF
- Procrea Fertility
- In Vitro Fertilization (IVF) Treatmen
 Treatment Market Overview.svg)
Highlights of The In Vitro Fertilization (IVF) Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- VF-ET
- ICSI
- PGD
- In Vitro Fertilization (IVF) Treatmen
- By Application:
- Fertility Clinics
- Hospitals
- Reaearch Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the In Vitro Fertilization (IVF) Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Treatment Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
In vitro fertilization (IVF) is a fertility treatment that uses sperm and eggs from a man or woman to create embryos. The embryos are then transferred into the uterus of a woman who may be trying to get pregnant.
Some of the major companies in the in vitro fertilization (ivf) treatment market are AMP Center St Roch, AVA Clinic, Bangkok IVF Center, Betamedics, Bloom Fertility Center, Bourn Hall, CHA Fertility Center, Chelsea and Westminster Hospital, Cloudnine Fertility, Cyprus IVF Centre, Dansk Fertilitetsklinik, FIV Marbella, Genea Oxford Fertility, Houston Fertility Center, IVI Panama, Lifesure Fertility and Gynaecology Centre, LIV Fertility Center, Manipal Fertility, OVA IVF, Procrea Fertility, In Vitro Fertilization (IVF) Treatmen.
The in vitro fertilization (ivf) treatment market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. In Vitro Fertilization (IVF) Treatment Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. In Vitro Fertilization (IVF) Treatment Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. In Vitro Fertilization (IVF) Treatment Market - Supply Chain
4.5. Global In Vitro Fertilization (IVF) Treatment Market Forecast
4.5.1. In Vitro Fertilization (IVF) Treatment Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. In Vitro Fertilization (IVF) Treatment Market Size (000 Units) and Y-o-Y Growth
4.5.3. In Vitro Fertilization (IVF) Treatment Market Absolute $ Opportunity
5. Global In Vitro Fertilization (IVF) Treatment Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. In Vitro Fertilization (IVF) Treatment Market Size and Volume Forecast by Type
5.3.1. VF-ET
5.3.2. ICSI
5.3.3. PGD
5.3.4. In Vitro Fertilization (IVF) Treatmen
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global In Vitro Fertilization (IVF) Treatment Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. In Vitro Fertilization (IVF) Treatment Market Size and Volume Forecast by Application
6.3.1. Fertility Clinics
6.3.2. Hospitals
6.3.3. Reaearch Centers
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global In Vitro Fertilization (IVF) Treatment Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. In Vitro Fertilization (IVF) Treatment Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global In Vitro Fertilization (IVF) Treatment Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. In Vitro Fertilization (IVF) Treatment Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global In Vitro Fertilization (IVF) Treatment Demand Share Forecast, 2019-2026
9. North America In Vitro Fertilization (IVF) Treatment Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America In Vitro Fertilization (IVF) Treatment Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America In Vitro Fertilization (IVF) Treatment Market Size and Volume Forecast by Application
9.4.1. Fertility Clinics
9.4.2. Hospitals
9.4.3. Reaearch Centers
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America In Vitro Fertilization (IVF) Treatment Market Size and Volume Forecast by Type
9.7.1. VF-ET
9.7.2. ICSI
9.7.3. PGD
9.7.4. In Vitro Fertilization (IVF) Treatmen
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America In Vitro Fertilization (IVF) Treatment Demand Share Forecast, 2019-2026
10. Latin America In Vitro Fertilization (IVF) Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America In Vitro Fertilization (IVF) Treatment Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America In Vitro Fertilization (IVF) Treatment Market Size and Volume Forecast by Application
10.4.1. Fertility Clinics
10.4.2. Hospitals
10.4.3. Reaearch Centers
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America In Vitro Fertilization (IVF) Treatment Market Size and Volume Forecast by Type
10.7.1. VF-ET
10.7.2. ICSI
10.7.3. PGD
10.7.4. In Vitro Fertilization (IVF) Treatmen
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America In Vitro Fertilization (IVF) Treatment Demand Share Forecast, 2019-2026
11. Europe In Vitro Fertilization (IVF) Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe In Vitro Fertilization (IVF) Treatment Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe In Vitro Fertilization (IVF) Treatment Market Size and Volume Forecast by Application
11.4.1. Fertility Clinics
11.4.2. Hospitals
11.4.3. Reaearch Centers
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe In Vitro Fertilization (IVF) Treatment Market Size and Volume Forecast by Type
11.7.1. VF-ET
11.7.2. ICSI
11.7.3. PGD
11.7.4. In Vitro Fertilzation (IVF) Treatmen
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe In Vitro Fertilization (IVF) Treatment Demand Share, 2019-2026
12. Asia Pacific In Vitro Fertilization (IVF) Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific In Vitro Fertilization (IVF) Treatment Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific In Vitro Fertilization (IVF) Treatment Market Size and Volume Forecast by Application
12.4.1. Fertility Clinics
12.4.2. Hospitals
12.4.3. Reaearch Centers
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific In Vitro Fertilization (IVF) Treatment Market Size and Volume Forecast by Type
12.7.1. VF-ET
12.7.2. ICSI
12.7.3. PGD
12.7.4. In Vitro Fertilization (IVF) Treatmen
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific In Vitro Fertilization (IVF) Treatment Demand Share, 2019-2026
13. Middle East & Africa In Vitro Fertilization (IVF) Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa In Vitro Fertilization (IVF) Treatment Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa In Vitro Fertilization (IVF) Treatment Market Size and Volume Forecast by Application
13.4.1. Fertility Clinics
13.4.2. Hospitals
13.4.3. Reaearch Centers
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa In Vitro Fertilization (IVF) Treatment Market Size and Volume Forecast by Type
13.7.1. VF-ET
13.7.2. ICSI
13.7.3. PGD
13.7.4. In Vitro Fertilization (IVF) Treatmen
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa In Vitro Fertilization (IVF) Treatment Demand Share, 2019-2026
14. Competition Landscape
14.1. Global In Vitro Fertilization (IVF) Treatment Market: Market Share Analysis
14.2. In Vitro Fertilization (IVF) Treatment Distributors and Customers
14.3. In Vitro Fertilization (IVF) Treatment Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. AMP Center St Roch
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. AVA Clinic
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Bangkok IVF Center
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Betamedics
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Bloom Fertility Center
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Bourn Hall
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. CHA Fertility Center
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Chelsea and Westminster Hospital
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Cloudnine Fertility
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Cyprus IVF Centre
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Dansk Fertilitetsklinik
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. FIV Marbella
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Genea Oxford Fertility
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Houston Fertility Center
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. IVI Panama
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Lifesure Fertility and Gynaecology Centre
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. LIV Fertility Center
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. Manipal Fertility
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. OVA IVF
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. Procrea Fertility
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
